Cargando…
COVID-19 in heart transplant recipients
Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19. We evaluated the clinical outcomes of heart transplant recipients in patients with COVID-19. Methods: We enrolled twenty-two COVID-19 cases of adult heart t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871157/ https://www.ncbi.nlm.nih.gov/pubmed/36699553 http://dx.doi.org/10.34172/jcvtr.2022.31583 |
_version_ | 1784877106213158912 |
---|---|
author | Taghavi, Sepideh Raffiei Jelodar, Hoda Rafati, Ali Naderi, Nasim Mirtajaddini, Marzieh Amin, Ahmad Valizadeh, Leili Omidvar, Razieh Kamali, Monireh Naseh, Soroush |
author_facet | Taghavi, Sepideh Raffiei Jelodar, Hoda Rafati, Ali Naderi, Nasim Mirtajaddini, Marzieh Amin, Ahmad Valizadeh, Leili Omidvar, Razieh Kamali, Monireh Naseh, Soroush |
author_sort | Taghavi, Sepideh |
collection | PubMed |
description | Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19. We evaluated the clinical outcomes of heart transplant recipients in patients with COVID-19. Methods: We enrolled twenty-two COVID-19 cases of adult heart transplantation from February 2020 to September 2021. Results: The most common symptoms in patients were fever and myalgia. The death occurred in 3 (13.6 %). Conclusion: Although heart transplantation mortality may increase in the acute rejection phase concomitant with COVID-19, immunosuppressive dose reduction may not be necessary for all heart transplant patients with COVID-19. |
format | Online Article Text |
id | pubmed-9871157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-98711572023-01-24 COVID-19 in heart transplant recipients Taghavi, Sepideh Raffiei Jelodar, Hoda Rafati, Ali Naderi, Nasim Mirtajaddini, Marzieh Amin, Ahmad Valizadeh, Leili Omidvar, Razieh Kamali, Monireh Naseh, Soroush J Cardiovasc Thorac Res Short Communication Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19. We evaluated the clinical outcomes of heart transplant recipients in patients with COVID-19. Methods: We enrolled twenty-two COVID-19 cases of adult heart transplantation from February 2020 to September 2021. Results: The most common symptoms in patients were fever and myalgia. The death occurred in 3 (13.6 %). Conclusion: Although heart transplantation mortality may increase in the acute rejection phase concomitant with COVID-19, immunosuppressive dose reduction may not be necessary for all heart transplant patients with COVID-19. Tabriz University of Medical Sciences 2022 2022-12-17 /pmc/articles/PMC9871157/ /pubmed/36699553 http://dx.doi.org/10.34172/jcvtr.2022.31583 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Taghavi, Sepideh Raffiei Jelodar, Hoda Rafati, Ali Naderi, Nasim Mirtajaddini, Marzieh Amin, Ahmad Valizadeh, Leili Omidvar, Razieh Kamali, Monireh Naseh, Soroush COVID-19 in heart transplant recipients |
title | COVID-19 in heart transplant recipients |
title_full | COVID-19 in heart transplant recipients |
title_fullStr | COVID-19 in heart transplant recipients |
title_full_unstemmed | COVID-19 in heart transplant recipients |
title_short | COVID-19 in heart transplant recipients |
title_sort | covid-19 in heart transplant recipients |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871157/ https://www.ncbi.nlm.nih.gov/pubmed/36699553 http://dx.doi.org/10.34172/jcvtr.2022.31583 |
work_keys_str_mv | AT taghavisepideh covid19inhearttransplantrecipients AT raffieijelodarhoda covid19inhearttransplantrecipients AT rafatiali covid19inhearttransplantrecipients AT naderinasim covid19inhearttransplantrecipients AT mirtajaddinimarzieh covid19inhearttransplantrecipients AT aminahmad covid19inhearttransplantrecipients AT valizadehleili covid19inhearttransplantrecipients AT omidvarrazieh covid19inhearttransplantrecipients AT kamalimonireh covid19inhearttransplantrecipients AT nasehsoroush covid19inhearttransplantrecipients |